APRE vs FSLR · $10.4M cap vs P/E 16, rev $2.10B
Aprea Therapeutics Inc (APRE) versus First Solar Inc (FSLR) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
First Solar Inc (FSLR) is a solar company listed on NASDAQ. It is led by Mark R. Widmar.
APRE does not have a complete income-statement cache yet.
Latest reported FSLR revenue for 2026-06-30 was $2.10B. Net income was $769.2M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
APRE currently screens at market cap $10.4M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
Not investment advice. Open the APRE and FSLR stock pages for the full models.
Not investment advice.